• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局灶性喉肌张力障碍的病理神经生理学基础与治疗:一项叙述性综述及两例在喉运动皮层应用经颅磁刺激的病例报告

The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex.

作者信息

Rogić Vidaković Maja, Gunjača Ivana, Bukić Josipa, Košta Vana, Šoda Joško, Konstantinović Ivan, Bošković Braco, Bilić Irena, Režić Mužinić Nikolina

机构信息

Laboratory for Human and Experimental Neurophysiology, Department of Neuroscience, University of Split School of Medicine, 21000 Split, Croatia.

Department of Medical Biology, University of Split School of Medicine, 21000 Split, Croatia.

出版信息

J Clin Med. 2022 Jun 15;11(12):3453. doi: 10.3390/jcm11123453.

DOI:10.3390/jcm11123453
PMID:35743523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224879/
Abstract

Focal laryngeal dystonia (LD) is a rare, idiopathic disease affecting the laryngeal musculature with an unknown cause and clinically presented as adductor LD or rarely as abductor LD. The most effective treatment options include the injection of botulinum toxin (BoNT) into the affected laryngeal muscle. The aim of this narrative review is to summarize the patho-neuro-physiological and genetic background of LD, as well as the standard recommended therapy (BoNT) and pharmacological treatment options, and to discuss possible treatment perspectives using neuro-modulation techniques such as repetitive transcranial magnetic stimulation (rTMS) and vibrotactile stimulation. The review will present two LD cases, patients with adductor and abductor LD, standard diagnostic procedure, treatments and achievement, and the results of cortical excitability mapping the primary motor cortex for the representation of the laryngeal muscles in the assessment of corticospinal and corticobulbar excitability.

摘要

局灶性喉肌张力障碍(LD)是一种罕见的特发性疾病,影响喉肌,病因不明,临床上表现为内收型LD,很少表现为外展型LD。最有效的治疗选择包括向受影响的喉肌注射肉毒杆菌毒素(BoNT)。本叙述性综述的目的是总结LD的病理神经生理学和遗传背景,以及标准推荐治疗(BoNT)和药物治疗选择,并讨论使用重复经颅磁刺激(rTMS)和振动触觉刺激等神经调节技术的可能治疗前景。该综述将介绍两例LD病例,内收型和外展型LD患者、标准诊断程序、治疗方法和成果,以及在评估皮质脊髓和皮质延髓兴奋性时对初级运动皮层进行皮质兴奋性映射以表示喉肌的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/f16f3641123a/jcm-11-03453-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/b9f3a03cbd3b/jcm-11-03453-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/023673194de3/jcm-11-03453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/706dd866add0/jcm-11-03453-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/f16f3641123a/jcm-11-03453-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/b9f3a03cbd3b/jcm-11-03453-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/023673194de3/jcm-11-03453-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/706dd866add0/jcm-11-03453-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba0c/9224879/f16f3641123a/jcm-11-03453-g004.jpg

相似文献

1
The Patho-Neurophysiological Basis and Treatment of Focal Laryngeal Dystonia: A Narrative Review and Two Case Reports Applying TMS over the Laryngeal Motor Cortex.局灶性喉肌张力障碍的病理神经生理学基础与治疗:一项叙述性综述及两例在喉运动皮层应用经颅磁刺激的病例报告
J Clin Med. 2022 Jun 15;11(12):3453. doi: 10.3390/jcm11123453.
2
Exploring Neurophysiological Mechanisms and Treatment Efficacies in Laryngeal Dystonia: A Transcranial Magnetic Stimulation Approach.探索喉肌张力障碍的神经生理机制及治疗效果:经颅磁刺激方法
Brain Sci. 2023 Nov 15;13(11):1591. doi: 10.3390/brainsci13111591.
3
Probing the inhibitory motor circuits in adductor laryngeal dystonia during a dystonia-unrelated task.在与喉肌痉挛无关的任务中探测内收性喉痉挛的抑制性运动回路。
Parkinsonism Relat Disord. 2023 Oct;115:105812. doi: 10.1016/j.parkreldis.2023.105812. Epub 2023 Aug 14.
4
Perceptions regarding communicative participation in individuals receiving botulinum toxin injections for laryngeal dystonia.关于接受肉毒杆菌毒素注射治疗喉肌张力障碍患者的交流参与度的认知。
Int J Lang Commun Disord. 2021 Nov;56(6):1296-1315. doi: 10.1111/1460-6984.12668. Epub 2021 Aug 28.
5
Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia.肉毒毒素治疗喉痉挛的短期和长期中枢作用。
Neurology. 2022 Sep 13;99(11):e1178-e1190. doi: 10.1212/WNL.0000000000200850. Epub 2022 Jun 28.
6
Abnormal motor cortex excitability during linguistic tasks in adductor-type spasmodic dysphonia.内收型痉挛性发音障碍患者在语言任务期间运动皮层兴奋性异常。
Eur J Neurosci. 2015 Aug;42(4):2051-60. doi: 10.1111/ejn.12977. Epub 2015 Jul 8.
7
Incidence and risk factors for secondary extralaryngeal dystonia in patients with laryngeal dystonia.喉肌张力障碍患者继发性喉外肌张力障碍的发病率及危险因素
Am J Otolaryngol. 2024 Jan-Feb;45(1):104090. doi: 10.1016/j.amjoto.2023.104090. Epub 2023 Oct 12.
8
Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia.肉毒毒素神经毒素疗法在喉部肌张力障碍的临床治疗中的应用。
Toxins (Basel). 2022 Dec 1;14(12):844. doi: 10.3390/toxins14120844.
9
Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: A 30-year experience.喉肌张力障碍的现象学、遗传学及中枢神经系统网络异常:30年经验总结
Laryngoscope. 2018 Jan;128 Suppl 1(Suppl 1):S1-S9. doi: 10.1002/lary.27003. Epub 2017 Dec 8.
10
Spasmodic Dysphonia.痉挛性发音障碍
Adv Otorhinolaryngol. 2020;85:133-143. doi: 10.1159/000456693. Epub 2020 Nov 9.

引用本文的文献

1
Exploring Neurophysiological Mechanisms and Treatment Efficacies in Laryngeal Dystonia: A Transcranial Magnetic Stimulation Approach.探索喉肌张力障碍的神经生理机制及治疗效果:经颅磁刺激方法
Brain Sci. 2023 Nov 15;13(11):1591. doi: 10.3390/brainsci13111591.

本文引用的文献

1
Effects of low-frequency repetitive transcranial magnetic stimulation in adductor laryngeal dystonia: a safety, feasibility, and pilot study.低频重复经颅磁刺激治疗内收性喉肌痉挛的安全性、可行性及初步研究。
Exp Brain Res. 2022 Feb;240(2):561-574. doi: 10.1007/s00221-021-06277-4. Epub 2021 Dec 2.
2
The prevalence of anxiety in adult-onset isolated dystonia: A systematic review and meta-analysis.成人起病的孤立性肌张力障碍中焦虑症的患病率:一项系统评价和荟萃分析。
Eur J Neurol. 2021 Dec;28(12):4238-4250. doi: 10.1111/ene.15050. Epub 2021 Aug 16.
3
Dystonia and leveraging oral pharmacotherapy.
肌张力障碍与口服药物治疗的杠杆作用。
J Neural Transm (Vienna). 2021 Apr;128(4):521-529. doi: 10.1007/s00702-021-02339-7. Epub 2021 Apr 20.
4
Laryngeal Dystonia: Multidisciplinary Update on Terminology, Pathophysiology, and Research Priorities.喉痉挛:术语、发病机制和研究重点的多学科更新。
Neurology. 2021 May 25;96(21):989-1001. doi: 10.1212/WNL.0000000000011922. Epub 2021 Apr 15.
5
The whole truth about botulinum toxin - a review.肉毒杆菌毒素的全部真相——一篇综述
Postepy Dermatol Alergol. 2020 Dec;37(6):853-861. doi: 10.5114/ada.2019.82795. Epub 2019 Feb 5.
6
Adductor Spasmodic Dysphonia Improves with Bilateral Thalamic Deep Brain Stimulation: Report of 3 Cases Done Asleep and Review of Literature.内收肌痉挛性发音障碍经双侧丘脑深部电刺激治疗后改善:3 例患者在睡眠中接受治疗的报告及文献复习。
Tremor Other Hyperkinet Mov (N Y). 2020 Dec 31;10:60. doi: 10.5334/tohm.575.
7
Genotype-Phenotype Relations for Isolated Dystonia Genes: MDSGene Systematic Review.孤立性肌张力障碍基因的基因型-表型关系:MDSGene 系统评价。
Mov Disord. 2021 May;36(5):1086-1103. doi: 10.1002/mds.28485. Epub 2021 Jan 27.
8
Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome.苍白球深部脑刺激治疗单基因肌张力障碍:基因对治疗结果的影响。
Front Neurol. 2021 Jan 8;11:630391. doi: 10.3389/fneur.2020.630391. eCollection 2020.
9
Isolated dystonia: clinical and genetic updates.孤立性肌张力障碍:临床和遗传学更新。
J Neural Transm (Vienna). 2021 Apr;128(4):405-416. doi: 10.1007/s00702-020-02268-x. Epub 2020 Nov 27.
10
KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation.KMT2B 相关疾病:表型谱的扩展和深部脑刺激的长期疗效。
Brain. 2020 Dec 5;143(11):3242-3261. doi: 10.1093/brain/awaa304.